Quantcast
Radio Facts
Home » BLOG » Howard University Salutes Black History Legend: Dr. Roland B. Scott, Pioneering Sickle Cell Researcher
HBCU

Howard University Salutes Black History Legend: Dr. Roland B. Scott, Pioneering Sickle Cell Researcher

Dr. Roland B. Scott was a groundbreaking medical researcher in an era of intense discrimination Blacks.



WASHINGTON, D. C. (February 22, 2019) Each year Black History Month attention to the role that leading African Americans have played in shaping American life. Howard University proudly puts the spotlight on the contributions of Dr. Roland B. Scott, whose tireless research and advocacy in sickle cell disease deserve to be remembered.

At the time of his death, on Dec 10, 2002, Dr. Scott was recognized as the father of research into sickle cell disease. He was a groundbreaking researcher in an era of intense discrimination against Blacks. He was the primary for the National Sickle Cell Control Act of 1972, and founding director of the Howard University Center for Sickle Cell Disease, the first center in the nation devoted to the disease. Dr. Scott was the first chair of pediatrics in the Howard University of Medicine and one of the first two African-American fellows of the American Academy of Pediatrics.

“Dr. Scott is the person who put sickle cell disease on the map,” says Dr. Oswaldo Castro, who was recruited to Howard University by Dr. Scott and later became director of the Center for Sickle Cell Disease. “He put sickle cell disease at the forefront of government health policies.”

Scott was born on 18, 1909 in Houston, and grew up there and in Kansas City, Missouri. He opted for Howard University for his undergraduate studies on his mother’s for him to be educated in a comfortable social environment. He studied chemistry and went on to earn a medical degree from the Howard University College of Medicine in 1934.



As a medical student, Scott was encouraged to study diseases that affected children and later he decided to focus on pediatric medicine. But Dr. Scott had difficulty obtaining a residency in pediatrics because, at the time, hospitals were taking only whites, Dr. Castro observed.

“Dr. Scott grew up during a time of discrimination, at a time when it was very difficult to get ahead,” Dr. Castro says. “Most people would have been frustrated by the difficulty, but he was able to triumph.”

In 1939, Dr. Scott returned to Howard University to an appointment as assistant professor of pediatrics. He spent the rest of his career there. After seeing many children with symptoms of sickle cell disease admitted to Howard University Hospital, Dr. Scott began to focus on study of disease.

Over the next few decades, Dr. Scott and co-workers at Howard University published hundreds of articles on sickle cell disease as well as on treatment methods. In 1948, Dr. Scott authored a pioneering scientific study on the incidence of red cell sickling in newborn infants. Outside of sickle cell disease, Dr. Scott was also the first to report growth and development norms for healthy African-American children, which became the basis of nationwide standards.

Among his challenges was persuading the government to provide funding for research. Dr. Scott lobbied the U.S. Congress tirelessly and testified on a number of occasions to get the legislation passed. His years of advocacy culminated in the passage of the Sickle Cell Anemia Control Act of 1971, which provided nationwide federal funding into the disease.

In 1972, Dr. Scott established Howard University’s Center for Sickle Cell Disease. In to implementing comprehensive patient and research into the disease, Dr. Scott organized yearly national conferences on blood diseases. His legacy continues now through lectures such that bear his name at Howard University.

The Howard University Center for Sickle Cell Disease remains a key U.S. institute for the study of new sickle cell drugs. The center has a history of treating a high volume of patients and, as a result, has participated in every major clinical trial that has led to FDA-approved medications for sickle cell disease.

Photo credit: Howard University Moorland-Spingarn Research Center.

For media inquiries, please Sholnn Freeman, [email protected]

About Howard University

Founded in 1867, Howard University is a private, research university that is comprised of 13 schools and colleges. Students pursue studies in more than 120 areas leading to undergraduate, graduate and professional degrees. The University operates with a commitment to Excellence in Truth and Service and has produced four Rhodes Scholars, 11 Truman Scholars, two Marshall Scholars, one Schwarzman Scholar, over 70 Fulbright Scholars and 22 Pickering Fellows. Howard also produces more on-campus African-American Ph.D. recipients than any other university in the United States.  For more information on Howard University visit www.howard.edu.

Related posts

Howard University Announces Isiah “Ike” Leggett as Convocation Speaker Sept. 20

imani.popejohns

Howard University’s Bachelor of Science in Nursing Program Celebrates 50th Anniversary with the First Nursing White Coat Ceremony

imani.popejohns

Alpha Kappa Alpha Attempts to Raise $1 Million for HBCUs in 24 Hours

Hassahn Liggins

Howard University Graduate School to Host the 2019 Annual Edward Bouchet National Graduate Forum, Sept 11-12

imani.popejohns

Howard University Relaunches Patricia Roberts Harris Public Affairs Fellowship – Applications Open Sept. 1 and Close Nov. 1

imani.popejohns

Howard University Featured in The Princeton Review’s “Best 385 Colleges” Guide for 2020

imani.popejohns

Leave a Comment

3 Shares
Share1
Tweet1
Share
Pin1